AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Nanogen Reaches Settlement.
Nanogen, Inc. (10398 Pacific Center Ct., San Diego, CA 92121; Tel: 858/410-4600, Fax: 858/410-4848) and Motorola, Inc. (1303 E. Algonquin Rd., Schaumburg, IL 60196; Tel: 847/576-5000, Fax: 847/576-5372) have announced a settlement agreement concluding the declaratory judgment action by Nanogen against Motorola, Genometrix, Inc. (2700 Research Forest Dr., The Woodlands, TX 77381; Tel: 281/465-5000, Fax: 281/465-5002) and Massachusetts Institute of Technology (MIT, Cambridge, MA) and Motorola's counterclaim against Nanogen.
Nanogen filed its complaint in April 2000, alleging non- infringement and invalidity of U.S. Patent No. 5,653,939, entitled "Optical and Electrical …
-
- Nanogen issued patents for biomarker discovery and nucleic acid manipulation...
-
News wire article from: Asia Africa Intelligence Wire
May 24, 2005
700+ words
-
- Nanogen expands patent portfolio in genetic analysis technologies.
-
News wire article from: Chemical Business Newsbase
December 22, 2005
700+ words
-
- Nanogen issued patent for enhancing molecular biological reactions.
-
News wire article from: Asia Africa Intelligence Wire
August 25, 2004
700+ words
-
- Nanogen issued patent for technology enabling assay development to detect...
-
News wire article from: Chemical Business Newsbase
November 17, 2005
700+ words
-
- Nanogen earns two patents for therapeutic and diagnostic use of biomarkers.
-
News wire article from: Chemical Business Newsbase
April 17, 2006
700+ words
